The U.S. FDA has granted Breakthrough Device Designation to Cala Trio™ for the treatment of action tremors in the hands … continue reading “FDA Breakthrough Device Designation for Cala Trio™ Therapy to Treat Action Tremors in Parkinson’s Disease”
Neuro
Largest Therapeutic Study Says Cala Trio Essential Tremor Therapy Safe and Effective
Bioelectronic medicine company, Cala Health, Inc. says its landmark PROspective study for SymPtomatic relief of Essential tremor with Cala Therapy (PROSPECT), demonstrates safe and effective … continue reading “Largest Therapeutic Study Says Cala Trio Essential Tremor Therapy Safe and Effective”
Two New FDA-Approved Bladder and Bowel Control Therapies
Medtronic plc, has received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads. Background … continue reading “Two New FDA-Approved Bladder and Bowel Control Therapies”
Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment
Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), has announced completion of enrollment in its … continue reading “Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment”
Newly Cleared Cranial Robotic System Sees First Paediatric Deployment
Phoenix Children’s Hospital, is the first health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth … continue reading “Newly Cleared Cranial Robotic System Sees First Paediatric Deployment”
Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™
Leicester’s Glenfield Hospital is to introduce the latest stroke-preventing cardiac implant, through Althea’s Consumable Management Service (CMS). Background Atrial fibrillation … continue reading “Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™”
CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software
Boston Scientific Corporation has announced the CE Mark approval of its Vercise™ Neural Navigator 3 directional Deep Brain Stimulation (DBS) programming … continue reading “CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software”
Multiple Silk Road Medical TCAR Presentations at 2018 VEITHsymposium
One-Year results of SVS TCAR surveillance project will feature
Penumbra Touts Thrombectomy Clinical Presentations at ISC
Penumbra neuro solutions in spotlight at major stroke congress this week
Neural Analytics Raises $15M for Lucid Brain Monitor Development
Specialist early stage venture firm Alpha Edison leads funding round
Portable Transcranial Doppler Technology Can Accurately Measure Early Strokes
Data Presented at 10th Society of Vascular and Interventional Annual Meeting
$10 Million U.S. Army Development Contract for Neural Analytics
Portable point of injury device assesses combat-related traumatic brain injury
New Funding Will Fuel Claret Medical’s U.S. Plans for Sentinel® Cerebral Protection System
Company closes $14.5million funding round
Benefits to Patients and Radiosurgery Departments Drive Adoption of Elekta’s Icon
Elekta’s Gamma Knife Icon now available in 50 health centers globally, Including Poliambulanza Foundation Hospital in Italy
Space Station Tech Behind New Surgical Robot Arm
Modus V™ robotic arm with digital microscope underpins Synaptive’s BrightMatter™ solution
New Software for Neural Analytics Lucid Portable Brain Monitoring System
Lucid Ultrasound System version 1.1 promises enhanced user experience to Improve usability and efficiency